Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease

B. Elam, Marshall; B. Hunninghake, Donald; Davis, Kathryn; Garg, Rekha; Johnson, Craig; Egan, Debra; B. Kostis, John; S. Sheps, David; A. Brinton, Eliot; the ASTEROID Investigators, for

doi:10.1001/jama.284.10.1263

Public

Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease

Published in JAMA • Sep 13, 2000

Authors:

Marshall B. Elam

Donald B. Hunninghake

Kathryn Davis

Abstract

CONTEXT: Although niacin increases low levels of high-density lipoprotein cholesterol (HDL-C), which frequently accompany diabetes, current guidelines do not recommend use of niacin in patients with diabetes because of concerns about adverse effects on glycemic control; however, this is based on lim...

Subject

Niacin

Medicine

Diabetes mellitus

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!